Current stage -Stage IV - Page 36 of 44 Posts on Medivizor
Navigation Menu

Current stage -Stage IV Posts on Medivizor

Degarelix (Firmagon) for advanced prostate cancer

Degarelix (Firmagon) for advanced prostate cancer

Posted by on Oct 4, 2014 in Prostate cancer | 0 comments

In a nutshell The authors evaluated the effectiveness of degarelix (Firmagon) for advanced prostate cancer. Some background Prostate cancer requires the androgen hormone testosterone to grow, and is described as a hormone-sensitive disease. Androgen deprivation therapy (ADT) is intended to reduce the production of androgens, or...

Read More

Can the addition of targeted drugs to chemotherapy improve response rates in advanced colorectal cancer?

Can the addition of targeted drugs to chemotherapy improve response rates in advanced colorectal cancer?

Posted by on Sep 28, 2014 in Colorectal cancer | 0 comments

In a nutshell The authors aimed to evaluate the addition of bevacizumab (Avastin) or cetuximab (Erbitux) to chemotherapy in advanced colorectal cancer. Some background Previously, the therapeutic options for patients who failed chemotherapy for advanced colorectal cancer have been limited. However, during the last few years, new targeted...

Read More

How is hormone receptor status related to prognostic factors in metastatic breast cancer?

How is hormone receptor status related to prognostic factors in metastatic breast cancer?

Posted by on Aug 18, 2014 in Breast cancer | 0 comments

In a nutshell This paper evaluates whether prognostic factors(factors that predict outcome of disease) have different effect depending on hormone receptor status in metastatic breast cancer Some background Metastatic breast cancer (cancer that has spread) is generally incurable with a low survival rate. Several prognostic factors have been...

Read More

Can adding biologic drugs to chemotherapeutic regimes improve cancer outcomes?

Can adding biologic drugs to chemotherapeutic regimes improve cancer outcomes?

Posted by on Aug 3, 2014 in Colorectal cancer | 0 comments

In a nutshell The authors reviewed overall survival, progression-free survival and response rate changes with the addition of biologic drugs to chemotherapeutic regimes in metastatic colorectal cancer. Some background It is estimated that approximately 20-25% of colorectal cancer patients present with distant metastases (spread of cancer to other...

Read More

Are there survival benefits associated with surgery in stage IV colorectal cancer?

Are there survival benefits associated with surgery in stage IV colorectal cancer?

Posted by on Jul 20, 2014 in Colorectal cancer | 0 comments

In a nutshell The authors evaluated the survival benefits associated with surgical removal of the primary tumor in stage IV colorectal cancer. Some background While surgery is the primary treatment for localized colorectal cancer (cancer that has not spread), surgical removal of the primary tumor in patients with incurable metastatic disease...

Read More

New targeted therapy for ALK-mutated lung cancer

New targeted therapy for ALK-mutated lung cancer

Posted by on Jun 28, 2014 in Lung cancer | 0 comments

In a nutshell This early phase trial investigated the safety and effect of ceritinib, a new ALK inhibitor, for the treatment of non-small cell lung cancer patients harboring mutations of the ALK gene. Some background Anaplastic lymphoma kinase (ALK) is an important protein involved in cell development. It is estimated that genetic changes that...

Read More